glp 1 weight loss fda approved The a new GLP-1 pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Market Overview: GLP-1 Agonists and
Description
10.1056/NEJMoa1603827 7
In the multiple ascending dose groups, weight loss persisted for up to 150 days after the final dose [8]
Novo Nordisk stated that the Wegovy pill will be available in January 2026
What to track weekly Weigh yourself at the same time on the same day each week, ideally first thing in the morning after using the bathroom
Risks associated with statin therapy: a systematic overview of randomized clinical trials
Noom Clinical: Is Medical Oversight or Coaching More Effective
